A pharmaceutical composition for treating cirrhotic ascites and a preparation method and application thereof
By preparing an appropriate dosage form through water extraction and enzymatic hydrolysis of medicinal compositions such as Anemarrhena asphodeloides, the problem of inconvenient decoction in traditional Chinese medicine treatment of ascites due to liver cirrhosis has been solved. Combined with Western medicine methods, significant therapeutic effects and ease of use have been achieved, reducing the economic burden on patients.
Patent Information
- Application Number
- CN202410548093.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-06
- Publication Date
- 2025-11-28
- Estimated Expiration
- 2044-05-06
AI Technical Summary
Current Western medicine treatments for ascites due to cirrhosis have unsatisfactory long-term effects and significant adverse reactions, while traditional Chinese medicine treatments present inconveniences in terms of decoction, carrying, and storage during long-term use.
The drug composition consists of six medicinal materials, including Anemarrhena asphodeloides, Dioscorea nipponica, Gynostemma pentaphyllum, Dioscorea opposita, Bidens pilosa, and Achyranthes bidentata. It is prepared into solid or liquid preparations through water extraction and enzymatic extraction. Combined with conventional Western medicine symptomatic treatment, it is made into granules, capsules, tablets, pills, mixtures or syrups for easy use by patients.
It significantly improves patients' clinical symptoms and enhances their quality of life, with an overall effective rate of 83.3%. The extraction rate of effective components is greatly improved, and it is low in cost, easy to use, highly safe, and reduces adverse reactions.